Stay updated with breaking news from Cogent Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) – Equities researchers at Leerink Partnrs increased their FY2024 earnings estimates for Cogent Biosciences in a note issued to investors on Monday, February 26th. Leerink Partnrs analyst A. Berens now anticipates that the technology company will post earnings per share of ($2.16) for the year, up from their […]
Key Insights Given the large stake in the stock by institutions, Cogent Biosciences' stock price might be vulnerable to...
Innoviva (NASDAQ:INVA – Get Rating) and Cogent Biosciences (NASDAQ:COGT – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk. Analyst Ratings This is a summary of current recommendations for […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) – HC Wainwright raised their Q2 2023 earnings estimates for shares of Cogent Biosciences in a report issued on Thursday, June 8th. HC Wainwright analyst R. Burns now anticipates that the technology company will earn ($0.56) per share for the quarter, up from their prior forecast of ($0.67). […]
Cogent Biosciences to Present at Jefferies Virtual Healthcare Conference 2021 News provided by Share this article Share this article CAMBRIDGE, Mass. and BOULDER, Colo., May 26, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, Chief Executive Officer and President, will present at Jefferies Virtual Healthcare Conference on Thursday, June 3 rd, from 11:30-11:55am ET. Access to the webcast of this event, as well as an archived recording, will be...